Identity and Access Management and Biometric Solutions Provider BIO-key Hosts Q3 Investor Call Friday, November 15th at 10am ET
BIO-key International (NASDAQ: BKYI), a provider of Identity and Access Management and Identity-Bound Biometric solutions, has scheduled its Q3 2024 earnings conference call for Friday, November 15th at 10 a.m. ET. The company will release its financial results after market close on Thursday. The call will be led by Chairman & CEO Mike DePasquale and CFO Cecilia Welch, featuring a Q&A session.
Investors can join via phone at 1-877-418-5460 (U.S.) or 1-412-717-9594 (International). A webcast replay will be available for 3 months, and audio replay can be accessed using code 7307131 at 1-877-344-7529 (U.S.) or 1-412-317-0088 (International).
BIO-key International (NASDAQ: BKYI), un fornitore di soluzioni di Identity and Access Management e biometriche legate all'identità, ha programmato la sua call sui risultati finanziari del Q3 2024 per venerdì 15 novembre alle 10:00 ET. L'azienda rilascerà i risultati finanziari dopo la chiusura del mercato di giovedì. La chiamata sarà guidata dal Presidente e CEO Mike DePasquale e dal CFO Cecilia Welch, includendo una sessione di domande e risposte.
Gli investitori possono partecipare via telefono al numero 1-877-418-5460 (U.S.) o 1-412-717-9594 (Internazionale). Una registrazione del webcast sarà disponibile per 3 mesi, e la registrazione audio può essere accessibile usando il codice 7307131 al numero 1-877-344-7529 (U.S.) o 1-412-317-0088 (Internazionale).
BIO-key International (NASDAQ: BKYI), un proveedor de soluciones de gestión de identidad y acceso, así como soluciones biométricas vinculadas a la identidad, ha programado su llamada de conferencia de resultados del Q3 2024 para el viernes 15 de noviembre a las 10 a.m. ET. La empresa dará a conocer sus resultados financieros después del cierre del mercado el jueves. La llamada será dirigida por el Presidente y CEO Mike DePasquale y la CFO Cecilia Welch, con una sesión de preguntas y respuestas.
Los inversionistas pueden unirse por teléfono al 1-877-418-5460 (EE.UU.) o 1-412-717-9594 (Internacional). Una grabación del webcast estará disponible durante 3 meses, y la grabación de audio se puede acceder utilizando el código 7307131 al 1-877-344-7529 (EE.UU.) o 1-412-317-0088 (Internacional).
BIO-key International (NASDAQ: BKYI)은 신원 및 접근 관리 솔루션과 신원 기반 생체인식 솔루션을 제공하는 기업으로, 2024년 3분기 실적 컨퍼런스 콜을 11월 15일 금요일 오전 10시(동부 표준시)에 진행할 예정입니다. 회사는 목요일 시장 종료 후에 재무 결과를 발표할 것입니다. 이번 콜은 회장兼 CEO인 마이크 디파스콸레와 CFO인 세실리아 웰치가 이끌며, 질의응답 세션도 포함될 예정입니다.
투자자들은 전화로 1-877-418-5460 (미국) 또는 1-412-717-9594 (국제)로 참여할 수 있습니다. 웹캐스트 녹화는 3개월간 제공되며, 오디오 녹음은 코드 7307131을 사용하여 1-877-344-7529 (미국) 또는 1-412-317-0088 (국제)로 접근할 수 있습니다.
BIO-key International (NASDAQ: BKYI), un fournisseur de solutions de gestion d'identité et d'accès ainsi que de solutions biométriques liées à l'identité, a programmé sa conférence téléphonique sur les résultats du T3 2024 pour le vendredi 15 novembre à 10 h, heure de l'Est. L'entreprise publiera ses résultats financiers après la clôture des marchés jeudi. L'appel sera dirigé par le président et PDG Mike DePasquale et la CFO Cecilia Welch, et comprendra une session de questions-réponses.
Les investisseurs peuvent rejoindre l'appel par téléphone au 1-877-418-5460 (États-Unis) ou au 1-412-717-9594 (international). Un replay du webcast sera disponible pendant 3 mois, et la rediffusion audio peut être accessible en utilisant le code 7307131 au 1-877-344-7529 (États-Unis) ou au 1-412-317-0088 (international).
BIO-key International (NASDAQ: BKYI), ein Anbieter von Identitäts- und Zugangsmanagement sowie identitätsgebundenen biometrischen Lösungen, hat seine Telefonkonferenz zu den Ergebnissen des Q3 2024 für Freitag, den 15. November um 10:00 Uhr ET angesetzt. Das Unternehmen wird seine finanziellen Ergebnisse nach Marktschluss am Donnerstag veröffentlichen. Das Gespräch wird von Chairman & CEO Mike DePasquale und CFO Cecilia Welch geleitet, und es wird eine Frage-und-Antwort-Runde geben.
Investoren können telefonisch unter 1-877-418-5460 (USA) oder 1-412-717-9594 (international) teilnehmen. Ein Webcast-Wiederholung wird für 3 Monate zur Verfügung stehen, und die Audiowiederholung kann mit dem Code 7307131 unter 1-877-344-7529 (USA) oder 1-412-317-0088 (international) abgerufen werden.
- None.
- None.
HOLMDEL, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management and Identity-Bound Biometric solutions, will host its Q3 2024 investor call Friday, November 15th at 10 a.m. ET. Results will be released after the market close on Thursday. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and Q&A session.
| Conference Details | ||
| Date / Time: | Friday, November 15th at 10 a.m. ET | |
| Call Dial In #: | 1-877-418-5460 U.S. or 1-412-717-9594 Int’l | |
| Live Webcast / Replay: | Webcast & Replay Link – Available for 3 months. | |
| Audio Replay: | 1-877-344-7529 U.S. or 1-412-317-0088 Int’l; code 7307131 | |
About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over 40 million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
| Engage with BIO-key | ||
| Facebook – Corporate: | https://www.facebook.com/BIOkeyInternational/ | |
| LinkedIn – Corporate: | https://www.linkedin.com/company/bio-key-international | |
| X – Corporate: | @BIOkeyIntl | |
| X – Investors: | @BIO_keyIR | |
| StockTwits: | BIO_keyIR | |
Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com
212-924-9800
FAQ
When is BIO-key's (BKYI) Q3 2024 earnings call scheduled?
How can investors access BIO-key's (BKYI) Q3 2024 earnings call?
When will BIO-key (BKYI) release its Q3 2024 financial results?
How long will BIO-key's (BKYI) Q3 2024 earnings call replay be available?
